These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry. Béliard S; Boccara F; Cariou B; Carrié A; Collet X; Farnier M; Ferrières J; Krempf M; Peretti N; Rabès JP; Varret M; Vimont A; Charrière S; Bruckert E; Atherosclerosis; 2018 Oct; 277():334-340. PubMed ID: 30270068 [TBL] [Abstract][Full Text] [Related]
7. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)? Kayikcioglu M; Tokgozoglu L; Dogan V; Ceyhan C; Tuncez A; Kutlu M; Onrat E; Alici G; Akbulut M; Celik A; Yesilbursa D; Sahin T; Sonmez A; Ozdogan O; Temizhan A; Kilic S; Bayram F; Sabuncu T; Coskun FY; Ildizli M; Durakoglugil E; Kirilmaz B; Yilmaz MB; Yigit Z; Yildirim AB; Gedikli O; Topcu S; Oğuz A; Demir M; Yenerçağ M; Yıldırır A; Demircan S; Yilmaz M; Kaynar LG; Aktan M; Durmus RB; Gokce C; Ozcebe Oİ; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O; Can LH Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069 [TBL] [Abstract][Full Text] [Related]
8. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice. Vohnout B; Fábryová Ľ; Klabník A; Kadurová M; Bálinth K; Kozárová M; Bugáňová I; Sirotiaková J; Rašlová K Atherosclerosis; 2018 Oct; 277():323-326. PubMed ID: 30270066 [TBL] [Abstract][Full Text] [Related]
9. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry. Vrablik M; Raslová K; Vohnout B; Blaha V; Satny M; Kyselak O; Vaclova M; Urbanek R; Maskova J; Soska V; Freiberger T Atherosclerosis; 2018 Oct; 277():355-361. PubMed ID: 30270071 [TBL] [Abstract][Full Text] [Related]
10. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C. van Delden XM; Huijgen R; Wolmarans KH; Brice BC; Barron JK; Blom DJ; Marais AD Atherosclerosis; 2018 Oct; 277():327-333. PubMed ID: 30270067 [TBL] [Abstract][Full Text] [Related]
11. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694 [TBL] [Abstract][Full Text] [Related]
12. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN Hormones (Athens); 2017 Jul; 16(3):306-312. PubMed ID: 30091117 [TBL] [Abstract][Full Text] [Related]
13. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN Hormones (Athens); 2017 Jul; 16(3):200-204. PubMed ID: 29278517 [TBL] [Abstract][Full Text] [Related]
14. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P; J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947 [TBL] [Abstract][Full Text] [Related]
15. Preliminary data of familial hypercholesterolemia (FH) patients in Romania. Dumitrescu A; Mosteoru S; Vinereanu D; Dan GA; Gaita L; Gaita D Atherosclerosis; 2018 Oct; 277():304-307. PubMed ID: 30270063 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study. Harada-Shiba M; Ako J; Arai H; Hirayama A; Murakami Y; Nohara A; Ozaki A; Uno K; Nakamura M Atherosclerosis; 2018 Oct; 277():362-368. PubMed ID: 30270072 [TBL] [Abstract][Full Text] [Related]
17. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk. Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017 [TBL] [Abstract][Full Text] [Related]
18. Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry. Saltijeral A; Pérez de Isla L; Alonso R; Muñiz O; Díaz-Díaz JL; Fuentes F; Mata N; de Andrés R; Díaz-Soto G; Pastor J; Pinilla JM; Zambón D; Pinto X; Badimón L; Mata P; Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):444-450. PubMed ID: 27913073 [TBL] [Abstract][Full Text] [Related]
19. Familial hypercholesterolemia treatments: Guidelines and new therapies. Raal FJ; Hovingh GK; Catapano AL Atherosclerosis; 2018 Oct; 277():483-492. PubMed ID: 30270089 [TBL] [Abstract][Full Text] [Related]